Loading...

Home
ETF
ORKA

ORKA

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ORKA News

Five Below Options Volume Hits 7,969 Contracts, 71.5% of Daily Average

Jan 09 2026NASDAQ.COM

Oruka to Present Novel Biologics at 44th Annual J.P. Morgan Healthcare Conference

Jan 06 2026Globenewswire

Sprott Silver Miners ETF Declines 2.3% with Americas Gold and Vizsla Silver Underperforming

Dec 31 2025NASDAQ.COM

Gilead Sciences Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Thursday

Nov 13 2025Benzinga

AutoZone Set to Surge Over 12%? Check Out 10 Leading Analyst Predictions for Thursday

Nov 13 2025Benzinga

BTIG Reaffirms Buy Rating for Oruka Therapeutics and Increases Price Target to $63

Nov 13 2025Benzinga

The Insider Report: Bulls Owe Their Success to Technology

Nov 02 2025Benzinga

Guggenheim Begins Coverage of Oruka Therapeutics with a Buy Rating and Sets Price Target at $60

Oct 27 2025Benzinga

BTIG Affirms Buy Rating for Oruka Therapeutics, Keeps $56 Price Target Intact

Sep 29 2025Benzinga

Wednesday's Major Stock Market Highlights: Morning News Summary!

Sep 17 2025TipRanks

Major Stocks Including Lyft, Oruka Therapeutics, Roivant Sciences, and Workday Rise on Wednesday

Sep 17 2025Benzinga

Clear Street Reaffirms Buy Rating on Oruka Therapeutics with $46 Price Target

Sep 17 2025Benzinga

Oruka Therapeutics Reports Positive Early-Stage Data for ORKA-001, Advocating for Longer Dosing Intervals and Announcing $180 Million Private Placement Plans

Sep 17 2025Yahoo Finance

New Fortress Energy Shares Surge 41%; Check Out 20 Stocks Making Moves in Premarket Trading

Sep 17 2025Benzinga

Oruka Surges as Leading Drug Exceeds AbbVie’s Skyrizi in Initial Trial Results

Sep 17 2025SeekingAlpha

Oruka Therapeutics Shares Encouraging Interim Results from Phase 1 Trial of ORKA-001

Sep 17 2025NASDAQ.COM